SMARCA4 and lung adenocarcinoma: We previously reported that loss of the catalytic subunits of SWI/SNF (SMARCA4 and SMARCA2) in lung adenocarcinoma tumors and lung cancer cell models altered KEAP1-NRF2 signaling [24].